PDE5A and cancer: Another novel 9-benzylaminoacridine derivatives 20a-b were found to inhibit both PDE5 (IC50 values are 7.43 ± 2.69 and 6.29 ± 1.18 μM, respectively) and DNA topoisomerase II enzyme, inducing apoptosis of cancer cells.